MUSTANG BIO, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
MUSTANG BIO, INC. (MBIO) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 87.89 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-23.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-23
- MUSTANG BIO, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 92.08M shares, a 39.50% increase year-over-year.
- MUSTANG BIO, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 91.14M shares, a 59.18% increase year-over-year.
- MUSTANG BIO, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 87.56M shares, a 94.48% increase year-over-year.
- MUSTANG BIO, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 80.47M shares, a 91.72% increase year-over-year.
- MUSTANG BIO, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 87.89M shares, a 67.12% increase from fiscal 2020.
- MUSTANG BIO, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 52.59M shares, a 45.83% increase from fiscal 2019.
- MUSTANG BIO, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 36.06M shares, a 33.81% increase from fiscal 2018.
- MUSTANG BIO, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 26.95M shares, a 6.72% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 7 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 10 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|
| 2021-12-31 | 92.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | 91.61M shares derived: average of 2 quarters · filed 2022-03-23 | 90.26M shares derived: average of 3 quarters · filed 2022-03-23 | 87.89M shares 10-K · filed 2022-03-23 | ||
| 2021-09-30 | 91.14M shares 10-Q · filed 2021-11-12 | 89.35M shares derived: average of 2 quarters · filed 2021-11-12 | 86.49M shares 10-Q · filed 2021-11-12 | 81.29M shares derived: average of 4 quarters · filed 2022-03-23 | ||
| 2021-06-30 | 87.56M shares 10-Q · filed 2021-08-16 | 84.03M shares 10-Q · filed 2021-08-16 | 78.01M shares derived: average of 3 quarters · filed 2022-03-23 | 72.82M shares derived: average of 4 quarters · filed 2022-03-23 | ||
| 2021-03-31 | 80.47M shares 10-Q · filed 2021-05-14 | 73.24M shares derived: average of 2 quarters · filed 2022-03-23 | 67.91M shares derived: average of 3 quarters · filed 2022-03-23 | 62.19M shares derived: average of 4 quarters · filed 2022-03-23 | ||
| 2020-12-31 | 66.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | 61.63M shares derived: average of 2 quarters · filed 2022-03-23 | 56.09M shares derived: average of 3 quarters · filed 2022-03-23 | 52.59M shares 10-K · filed 2022-03-23 | ||
| 2020-09-30 | 57.25M shares 10-Q · filed 2021-11-12 | 51.14M shares derived: average of 2 quarters · filed 2021-11-12 | 48.12M shares 10-Q · filed 2021-11-12 | 46.06M shares derived: average of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | 45.02M shares 10-Q · filed 2021-08-16 | 43.50M shares 10-Q · filed 2021-08-16 | 42.33M shares derived: average of 3 quarters · filed 2021-08-16 | 41.71M shares derived: average of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | 41.97M shares 10-Q · filed 2021-05-14 | 40.98M shares derived: average of 2 quarters · filed 2021-05-14 | 40.61M shares derived: average of 3 quarters · filed 2021-05-14 | 39.54M shares derived: average of 4 quarters · filed 2021-05-14 | ||
| 2019-12-31 | 39.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | 39.93M shares derived: average of 2 quarters · filed 2021-03-24 | 38.72M shares derived: average of 3 quarters · filed 2021-03-24 | 36.06M shares 10-K · filed 2021-03-24 | ||
| 2019-09-30 | 39.88M shares 10-Q · filed 2020-11-06 | 38.09M shares derived: average of 2 quarters · filed 2020-11-06 | 34.75M shares 10-Q · filed 2020-11-06 | 32.83M shares derived: average of 4 quarters · filed 2020-11-06 | ||
| 2019-06-30 | 36.31M shares 10-Q · filed 2020-08-10 | 32.15M shares 10-Q · filed 2020-08-10 | 30.48M shares derived: average of 3 quarters · filed 2020-08-10 | 29.65M shares derived: average of 4 quarters · filed 2020-08-10 | ||
| 2019-03-31 | 27.95M shares 10-Q · filed 2020-05-11 | 27.56M shares derived: average of 2 quarters · filed 2020-05-11 | 27.43M shares derived: average of 3 quarters · filed 2020-05-11 | 27.34M shares derived: average of 4 quarters · filed 2020-05-11 | ||
| 2018-12-31 | 27.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 27.16M shares derived: average of 2 quarters · filed 2020-03-16 | 27.14M shares derived: average of 3 quarters · filed 2020-03-16 | 26.95M shares 10-K · filed 2020-03-16 | ||
| 2018-09-30 | 27.15M shares 10-Q · filed 2019-11-12 | 27.12M shares derived: average of 2 quarters · filed 2019-11-12 | 26.87M shares 10-Q · filed 2019-11-12 | 26.71M shares derived: average of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | 27.09M shares 10-Q · filed 2019-08-09 | 26.73M shares 10-Q · filed 2019-08-09 | 26.56M shares derived: average of 3 quarters · filed 2019-08-09 | 26.47M shares derived: average of 4 quarters · filed 2019-08-09 | ||
| 2018-03-31 | 26.39M shares 10-Q · filed 2019-05-10 | 26.29M shares derived: average of 2 quarters · filed 2019-05-10 | 26.26M shares derived: average of 3 quarters · filed 2019-05-10 | 26.24M shares derived: average of 4 quarters · filed 2019-05-10 | ||
| 2017-12-31 | 26.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | 26.19M shares derived: average of 2 quarters · filed 2019-03-18 | 26.19M shares derived: average of 3 quarters · filed 2019-03-18 | 25.25M shares 10-K · filed 2019-03-18 | ||
| 2017-09-30 | 26.19M shares 10-Q · filed 2018-11-13 | 26.18M shares derived: average of 2 quarters · filed 2018-11-13 | 24.94M shares 10-Q · filed 2018-11-13 | 22.12M shares derived: average of 4 quarters · filed 2018-11-13 | ||
| 2017-06-30 | 26.18M shares 10-Q · filed 2018-08-13 | 24.30M shares 10-Q · filed 2018-08-13 | 20.77M shares derived: average of 3 quarters · filed 2018-08-13 | 18.10M shares derived: average of 4 quarters · filed 2018-08-13 | ||
| 2017-03-31 | 22.40M shares 10-Q · filed 2018-05-14 | 18.06M shares derived: average of 2 quarters · filed 2018-05-14 | 15.40M shares derived: average of 3 quarters · filed 2018-05-14 | 14.11M shares derived: average of 4 quarters · filed 2018-05-14 | ||
| 2016-12-31 | 13.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | 11.90M shares derived: average of 2 quarters · filed 2018-03-29 | 11.35M shares derived: average of 3 quarters · filed 2018-03-29 | 11.03M shares 10-K · filed 2018-03-29 | ||
| 2016-09-30 | 10.09M shares 10-Q · filed 2017-11-14 | 10.17M shares derived: average of 2 quarters · filed 2017-11-14 | 10.13M shares 10-Q · filed 2017-11-14 | |||
| 2016-06-30 | 10.25M shares 10-Q · filed 2017-08-14 | 10.15M shares 10-Q · filed 2017-08-14 | ||||
| 2016-03-31 | 10.05M shares 10-Q · filed 2017-05-15 | |||||
| 2015-12-31 | 9.99M shares 10-K · filed 2018-03-29 | |||||
| 2015-09-30 | 10.00M shares 10-Q · filed 2016-11-14 | 9.99M shares 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |